
A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2â advanced breast cancer
Keywords: بقا بدون پیشرفت; Endocrine therapy; Everolimus; Hormone receptor-positive advanced breast cancer; mTOR inhibitor; Overall survival; Progression-free survival;